Patients with visceral leishmaniasis show high IL-6 serum levels during the evolution of the disease, as this cytokine acts by blocking macrophage activation, in addition to its microbicidal activity [22, 23]. The gene discussed is IL6; the disease is visceral leishmaniasis.